Fairhaven Wealth Management’s Eli Lilly LLY Stock Holding History

Fairhaven Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$528K	Buy	684 +89	+15%	+$73.7K	0.17%	62
2024 Q3	$527K	Buy	595 +103	+21%	+$92.6K	0.16%	63
2024 Q2	$445K	Sell	492 -45	-8%	-$36K	0.15%	65
2024 Q1	$418K	Hold	537	–	–	0.14%	66
2023 Q4	$313K	Sell	537 -161	-23%	-$94K	0.11%	78
2023 Q3	$375K	Hold	698	–	–	0.15%	69
2023 Q2	$327K	Buy	+698	New	+$293K	0.13%	80
2022 Q4	$329K	Sell	898 -8	-0.9%	-$2.84K	0.14%	70
2022 Q3	$293K	Buy	906 +8	+0.9%	+$2.54K	0.13%	75
2022 Q2	$291K	Sell	898 -25	-3%	-$7.5K	0.14%	74
2022 Q1	$264K	Buy	923 +23	+3%	+$5.92K	0.11%	94
2021 Q4	$249K	Sell	900 -9	-1%	-$2.28K	0.1%	91
2021 Q3	$210K	Hold	909	–	–	0.09%	104
2021 Q2	$209K	Buy	+909	New	+$183K	0.08%	110

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fairhaven Wealth Management's LLY Position: Q4 2024 in Review

Fairhaven Wealth Management increased its Eli Lilly (LLY) stake by 15% in Q4 2024, buying an estimated $73.7K and bringing the position to 684 shares worth $528K. The position accounts for 0.17% of the portfolio, ranked #62.

Fairhaven Wealth Management first reported a position in LLY in Q2 2021 and has held it in 14 quarters since. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

Fairhaven Wealth Management held 684 shares of Eli Lilly worth $528K as of Q4 2024.
Fairhaven Wealth Management bought 89 Eli Lilly shares in Q4 2024, an estimated $73.7K.
Eli Lilly made up 0.17% of Fairhaven Wealth Management's portfolio in Q4 2024, its #62 holding.
Fairhaven Wealth Management first reported a position in Eli Lilly in Q2 2021 and has held it in 14 quarters since.
3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Fairhaven Wealth Management's 13F filing for Q4 2024, filed 4 Feb 2025.